GFG Capital LLC lessened its position in Zoetis Inc. (NYSE:ZTS – Free Report) by 38.4% in the 3rd quarter, Holdings Channel reports. The fund owned 1,355 shares of the company’s stock after selling 843 shares during the period. GFG Capital LLC’s holdings in Zoetis were worth $265,000 as of its most recent filing with the SEC.
Other hedge funds also recently made changes to their positions in the company. Webster Bank N. A. grew its holdings in Zoetis by 89.1% in the first quarter. Webster Bank N. A. now owns 174 shares of the company’s stock valued at $29,000 after purchasing an additional 82 shares during the period. Quarry LP lifted its holdings in Zoetis by 273.2% in the second quarter. Quarry LP now owns 209 shares of the company’s stock worth $36,000 after purchasing an additional 153 shares during the period. LRI Investments LLC acquired a new stake in Zoetis in the 1st quarter valued at about $43,000. Central Valley Advisors LLC acquired a new stake in Zoetis in the 2nd quarter valued at about $49,000. Finally, Future Financial Wealth Managment LLC purchased a new stake in Zoetis during the first quarter valued at about $51,000. Institutional investors and hedge funds own 92.80% of the company’s stock.
Zoetis Stock Down 2.0 %
Shares of NYSE:ZTS opened at $189.45 on Tuesday. The business has a 50 day simple moving average of $189.09 and a two-hundred day simple moving average of $177.34. The company has a debt-to-equity ratio of 1.32, a current ratio of 3.45 and a quick ratio of 2.09. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $201.92. The firm has a market capitalization of $86.45 billion, a PE ratio of 36.50, a price-to-earnings-growth ratio of 3.00 and a beta of 0.89.
Zoetis Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be issued a $0.432 dividend. The ex-dividend date of this dividend is Thursday, October 31st. This represents a $1.73 annualized dividend and a yield of 0.91%. Zoetis’s dividend payout ratio (DPR) is presently 33.14%.
Analysts Set New Price Targets
A number of equities analysts recently commented on ZTS shares. Argus upgraded Zoetis to a “strong-buy” rating in a report on Friday, August 9th. BTIG Research increased their price objective on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Piper Sandler lifted their price objective on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 14th. Stifel Nicolaus raised their target price on Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, September 18th. Finally, JPMorgan Chase & Co. boosted their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Ten research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $221.44.
Get Our Latest Analysis on ZTS
About Zoetis
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Read More
- Five stocks we like better than Zoetis
- What Investors Need to Know About Upcoming IPOs
- Buffett Trims BAC Holdings:What It Means for the Stock’s Future
- What is the S&P/TSX Index?
- Bank of America Sees Gold as the Last Safe Haven: Top 3 Picks
- Why Are These Companies Considered Blue Chips?
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.